Kallum Titchmarsh

Stock Analyst at Morgan Stanley

(4.57)
# 1,003
Out of 5,136 analysts
230
Total ratings
66.7%
Success rate
16%
Average return

Stocks Rated by Kallum Titchmarsh

Guardant Health
Oct 20, 2026
Reiterated: Buy
Price Target: $200
Current: $144.03
Upside: +38.86%
Agilent Technologies
Oct 13, 2026
Rated: Buy
Price Target: $175 → $190
Current: $172.92
Upside: +9.88%
Adaptive Biotechnologies
Oct 13, 2026
Reiterated: Hold
Price Target: $27
Current: $27.87
Upside: -3.12%
Avantor
Oct 13, 2026
Rated: Hold
Price Target: $14 → $15
Current: $15.32
Upside: -2.09%
Charles River Laboratories International
Oct 13, 2026
Rated: Buy
Price Target: $300 → $340
Current: $335.52
Upside: +1.34%
Danaher
Oct 13, 2026
Rated: Buy
Price Target: $220 → $240
Current: $229.91
Upside: +4.39%
GRAIL
Oct 13, 2026
Reiterated: Hold
Price Target: $120
Current: $105.60
Upside: +13.64%
Natera
Oct 13, 2026
Rated: Buy
Price Target: $355 → $435
Current: $288.48
Upside: +50.79%
Thermo Fisher Scientific
Oct 13, 2026
Rated: Buy
Price Target: $650 → $730
Current: $691.33
Upside: +5.59%
10x Genomics
Oct 13, 2026
Rated: Hold
Price Target: $40 → $70
Current: $54.99
Upside: +27.30%
Reiterated: Hold
Price Target: $5.5 → $5
Current: $5.63
Upside: -11.19%
Reiterated: Hold
Price Target: $1,450 → $1,575
Current: $1,727.26
Upside: -8.82%
Rated: Hold
Price Target: $20
Current: $15.53
Upside: +28.78%
Upgraded: Buy
Price Target: $365 → $400
Current: $417.80
Upside: -4.26%
Rated: Buy
Price Target: $19 → $21
Current: $18.65
Upside: +12.60%
Rated: Hold
Price Target: $240 → $270
Current: $264.73
Upside: +1.99%
Reiterated: Hold
Price Target: $430
Current: $453.42
Upside: -5.17%
Reiterated: Hold
Price Target: $35 → $40
Current: $46.86
Upside: -14.64%
Rated: Sell
Price Target: $47 → $44
Current: $24.01
Upside: +83.26%
Reiterated: Buy
Price Target: $70
Current: $64.76
Upside: +8.09%
Rated: Hold
Price Target: $9 → $13
Current: $14.80
Upside: -12.16%
Reiterated: Buy
Price Target: $100 → $68
Current: $70.50
Upside: n/a
Reiterated: Buy
Price Target: $200 → $182
Current: $59.12
Upside: n/a
Reiterated: Buy
Price Target: $130 → $160
Current: $90.83
Upside: n/a
Reiterated: Hold
Price Target: $20 → $15
Current: $6.25
Upside: n/a
Reiterated: Hold
Price Target: $10
Current: $4.42
Upside: n/a
Reiterated: Buy
Price Target: $19
Current: $23.41
Upside: n/a
Reiterated: Hold
Price Target: $260
Current: $320.62
Upside: n/a
Reiterated: Hold
Price Target: $10 → $11
Current: $6.78
Upside: n/a
Reiterated: Hold
Price Target: $5 → $4
Current: $10.59
Upside: n/a